Skip to main content
TSUMURA & CO. logo

TSUMURA & CO. — Investor Relations & Filings

Ticker · 4540 ISIN · JP3535800001 LEI · 3538005RS3M1OVJLC663 T Manufacturing
Open in API
Filings indexed 68 across all filing types
Latest filing 2023-06-29 Annual Report
Country JP Japan
Listing T 4540

About TSUMURA & CO.

https://www.tsumura.co.jp/english/

TSUMURA & CO. is a developer and manufacturer of pharmaceuticals derived from natural substances, specializing in Kampo medicine, a traditional form of Japanese herbal medicine. The company's portfolio includes a wide range of prescription Kampo formulations, which are delivered to patients through medical institutions, as well as over-the-counter (OTC) Kampo medicines and other wellness products such as herbal bath salts. Tsumura manages a comprehensive value chain, controlling the entire process from the procurement of raw herbal materials to the production of finished granular formulations and extracts. The company's approach integrates traditional knowledge with modern scientific research and quality control standards to provide treatments across various therapeutic areas, aiming to achieve harmony between mind and body.

Recent filings

Filing Released Lang Actions
有価証券報告書－第87期(2022/04/01－2023/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It explicitly states the document type as '有価証券報告書' (Securities Report), cites the Financial Instruments and Exchange Act Article 24, and covers a full fiscal year (第87期, 2022-04-01 to 2023-03-31). The presence of XBRL-like tags and comprehensive financial disclosure confirms it is the primary annual filing. FY 2023
2023-06-29 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-8. It serves as an officer certification confirming the accuracy of the quarterly report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a quarterly report. Q3 2022
2023-02-06 Japanese
四半期報告書－第87期第3四半期(2022/10/01－2022/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) for Tsumura & Co. for the period ending December 31, 2022. It contains comprehensive financial statements, including the balance sheet, income statement, and management analysis, which are characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself. 9M 2023
2023-02-06 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements for the period ending September 30, 2022. Since it is a specific regulatory requirement for filing financial reports in Japan and does not fit into the 'Interim Report' category itself (which would be the full financial report), it is best classified as a Regulatory Filing.
2022-11-07 Japanese
四半期報告書－第87期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Tsumura & Co. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MD&A), and shareholder information for the second quarter of the fiscal year ending March 2023. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2023
2022-11-07 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically accompanying a Quarterly Report (Dai-ichi shihanki hokokusho). It confirms the accuracy of the quarterly report for the period ending June 30, 2022. Since this is a regulatory filing confirming the contents of a quarterly report and does not contain the full financial statements themselves, it falls under the category of general regulatory filings.
2022-08-04 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.